SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-20-008172
Filing Date
2020-05-11
Accepted
2020-05-11 09:23:36
Documents
7
Period of Report
2020-05-11

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 34801
2 ex4-1.htm EX-4.1 116917
3 ex5-1.htm EX-5.1 18155
4 ex10-1.htm EX-10.1 269348
5 ex99-1.htm EX-99.1 13529
6 ex5-1_001.jpg GRAPHIC 5918
7 ex5-1_002.jpg GRAPHIC 13766
  Complete submission text file 0001493152-20-008172.txt   481056
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 20862916
SIC: 2834 Pharmaceutical Preparations